摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aS,4S,6aR)-4-hept-6-ynyl-tetrahydro-thieno[3,4-d]imidazol-2-one | 887915-53-9

中文名称
——
中文别名
——
英文名称
(3aS,4S,6aR)-4-hept-6-ynyl-tetrahydro-thieno[3,4-d]imidazol-2-one
英文别名
4S-[(3aS,6aR)-hept-6-ynyl]tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one;DecarboxyBiotin-Alkyne;(3aS,4S,6aR)-4-hept-6-ynyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one
(3aS,4S,6aR)-4-hept-6-ynyl-tetrahydro-thieno[3,4-d]imidazol-2-one化学式
CAS
887915-53-9
化学式
C12H18N2OS
mdl
——
分子量
238.354
InChiKey
HWFZBYFQQMRYQB-DCAQKATOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    459.4±30.0 °C(Predicted)
  • 密度:
    1.109±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Halogenation of Biotin Protein Ligase Inhibitors Improves Whole Cell Activity against Staphylococcus aureus
    摘要:
    We report the synthesis and evaluation of 5-halogenated-1,2,3-triazoles as inhibitors of biotin protein ligase from Staphylococcus aureus. The halogenated compounds exhibit significantly improved antibacterial activity over their nonhalogenated counterparts. Importantly, the 5-fluoro-1,2,3-triazole compound 4c displays antibacterial activity against S. aureus ATCC49775 with a minimum inhibitory concentration (MIC) of 8 mu g/mL.
    DOI:
    10.1021/acsinfecdis.7b00134
  • 作为产物:
    描述:
    D-生物素甲酯吡啶 、 lithium aluminium tetrahydride 、 lithium bromide 作用下, 以 四氢呋喃二甲基亚砜丁酮 为溶剂, 生成 (3aS,4S,6aR)-4-hept-6-ynyl-tetrahydro-thieno[3,4-d]imidazol-2-one
    参考文献:
    名称:
    具有抗菌活性的生物素类似物是生物素蛋白连接酶的有效抑制剂。
    摘要:
    迫切需要开发新的抗生素来抵抗耐药细菌的繁殖,例如临床上重要的金黄色葡萄球菌。基本的多功能酶生物素蛋白连接酶(BPL)是新抗生素的潜在药物靶标之一。我们报告了一系列生物素类似物的合成和表征,这些生物素类似物具有针对来自金黄色葡萄球菌,大肠杆菌和智人的BPL的活性。鉴定出K i <100 nM的两种有效抑制剂对一组金黄色葡萄球菌临床分离株具有抗菌活性(MIC 2-16杯/ mL)。鉴定并表征了具有高配体效率和同工酶之间选择性> 20倍的化合物。抗菌作用方式显示为通过抑制BPL。BPL和抑制剂之间的双分子相互作用是通过表面等离振子共振研究和X射线晶体学确定的。这些发现为具有更高效力和选择性的第二代抑制剂和抗生素铺平了道路。
    DOI:
    10.1021/ml300106p
点击查看最新优质反应信息

文献信息

  • A template guided approach to generating cell permeable inhibitors of Staphylococcus aureus biotin protein ligase
    作者:Ashleigh S. Paparella、Jiage Feng、Beatriz Blanco-Rodriguez、Zikai Feng、Wanida Phetsang、Mark A.T. Blaskovich、Matthew A. Cooper、Grant W. Booker、Steven W. Polyak、Andrew D. Abell
    DOI:10.1016/j.tet.2017.10.032
    日期:2018.3
    Inhibitors of biotin protein ligase (BPL) are novel antimicrobial compounds with the potential to treat infections caused by bacteria resistant to current antibiotics. A novel BPL inhibitor (12, Ki 1.4 μM) was synthesized from biotin acetylene and an azide-functionalized analogue of fluorescent nitrobenzofurazan by Cu(I) catalysed cycloaddition and also by template guided synthesis using wild-type
    生物素蛋白连接酶(BPL)抑制剂是新型抗菌化合物,具有治疗由对目前抗生素具有抗性的细菌引起的感染的潜力。一种新的BPL抑制剂(12,K i 1.4μM)是由生物素乙炔和叠氮基官能化的荧光硝基苯并呋喃类似物通过Cu(I)催化的环加成反应合成的,也通过模板指导的合成方法使用了金黄色葡萄球菌的野生型BPL合成的。基于LC / HRMS的检测与使用突变BPL的先前报告相比提供了更高的灵敏度,并证明了其对其他BPL的适用性。超成像荧光显微镜显示金黄色葡萄球菌细胞质中有12种积累,但没有大肠杆菌。这种新颖的荧光探针可用于获得对金黄色葡萄球菌中BPL抑制剂的摄取,外排和代谢机制的新见解。
  • Molecular Recognition Studies on Naphthyridine Derivatives
    作者:José Carlos Iglesias-Sánchez、Dolores Santa María、Rosa M. Claramunt、José Elguero
    DOI:10.3390/molecules15031213
    日期:——
    The association constants Kb of three hosts I–III designed to have both enhanced hydrogen bonding donor strength and conformational preorganization with biotin analogues 1–5 are reported. 1H-NMR titrations under two different concentration conditions have been employed to determine the association constants Kb. A statistical analysis using a presence absence matrix has been applied to calculate the different contributions. Hydrogen bond interactions make naphthyridine derivatives II and III potent binders and effective receptors for (+)-biotin methyl ester (1), due to the complex stabilization by additional hydrogen bonds.
    报告了设计用于增强氢键供体强度和构象预组织的生物素类似物 1-5 的三种宿主 I-III 的关联常数 Kb。采用两种不同浓度条件下的 1H-NMR 滴定法来确定关联常数 Kb。使用存在缺失矩阵进行统计分析,计算出不同的贡献。氢键相互作用使萘啶衍生物 II 和 III 成为(+)-生物素甲酯 (1) 的强效结合剂和有效受体,这是因为额外的氢键使复合物稳定。
  • [EN] NOVEL ANTIMICROBIAL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS ANTIMICROBIENS
    申请人:ADELAIDE RES & INNOVATION PTY
    公开号:WO2013040647A1
    公开(公告)日:2013-03-28
    A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.
    披萨店的招牌菜是各种口味的披萨,包括经典的意大利香肠披萨、夏威夷披萨、墨西哥辣椒披萨等。
  • Optimising in situ click chemistry: the screening and identification of biotin protein ligase inhibitors
    作者:William Tieu、Tatiana P. Soares da Costa、Min Y. Yap、Kelly L. Keeling、Matthew C. J. Wilce、John C. Wallace、Grant W. Booker、Steven W. Polyak、Andrew D. Abell
    DOI:10.1039/c3sc51127h
    日期:——
    ligase (SaBPL) is used to enhance the turnover rate for the reaction of biotin alkyne with an azide to give a triazole. This allows the enzyme to select the optimum triazole-based inhibitor using a library of such azides in a single experiment with greatly improved efficiency and sensitivity of detection, difficulties that can restrict the general utility of a multi-component in situ click approach to ligand
    金黄色葡萄球菌的“泄漏突变体”(Sa BPL-R122G) 生物素蛋白连接酶(Sa BPL)用于提高生物素炔烃与叠氮化物反应生成三唑的周转率。这使得酶可以在单个实验中使用此类叠氮化合物库选择最佳的基于三唑的抑制剂,从而大大提高了检测效率和检测灵敏度,这些困难可能限制了多组分原位点击方法在配体优化中的通用性。
  • NOVEL ANTIMICROBIAL COMPOUNDS
    申请人:MONASH UNIVERSITY
    公开号:US20140296177A1
    公开(公告)日:2014-10-02
    A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.
    披露了一种新型生物素蛋白连接酶(BPL)抑制剂,对包括临床重要的甲氧西林耐药金黄色葡萄球菌(MRSA)在内的多种金黄色葡萄球菌具有抗菌活性,并且是无毒的。
查看更多

同类化合物

生物素-C5-叠氮 樟磺咪芬 四氢-4-(5-羟戊基)-(3AS,4S,6AR)-1H-噻吩并[3,4-D]咪唑-2(3H)-酮 咪噻吩 利地霉素 5-硫杂-1,2A-二氮杂环戊并[Cd]并环戊二烯 1,3-二苄基-2-氧代十氢噻吩并[1',2':1,2]噻吩并[3,4-d]咪唑-5-鎓溴化物 (3AS,4S,6AR)-1,3-二苄基-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-甲醛 (3aS,4S,6aR)-4-(5-(1-(2-hydroxybenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one (3aS,4S,6aR)-4-(5-(1-(3-methoxybenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one methyl (4E,Z)-6-({5-[(3aS,4S,6aR)-1,3-bis(4-methoxybenzyl)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}oxy)hex-4-enoate 1H-thieno<3,4-d>imidazol-2(3H)-one, tetrahydro-4-(5-chloropentyl)-, <3aS-(3aα,4β,6aα)>- (3aS,4Z,6aR)-5-{hexahydro-2-oxo-4H-thieno[3,4-d]imidazol-4-ylidene}pentanoic acid methyl ester (3aS,6aR)-1,3-dibenzyl-tetrahydro-1H-thieno[3,4-d]-imidazole-2(3H)-one-4-yl-pentanoic acid (3aS,4S,6aR)-4-(5-(1-(4-iodobenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 1-amino-17-N-(biotinylamido)-3,6,9,12,15-pentaoxaheptadecane (3aS,4S,6aR)-4-(4-isocyanatobutyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 2-[1-Hydroxy-5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentylidene]-5,5-dimethyl-cyclohexane-1,3-dione (3aS,4S,6aR)-4-(4-aminobut-1-yl)hexahydro-1H-thieno[3,4-d]imidazolidin-2-one hydrochloride Methyl-bisnorbiotinyl-keton 3,4-(1',3'-Dibenzyl-2'-oxoimidazolido)-2-hydroxy-thiophen 5-[({4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}carbamoyl)amino]pentanoic acid tert-butyl 5-[({4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}carbamoyl)amino]pentanoate 1-{5-[(2,5-dioxopyrrolidin-1-yl)oxy]-5-oxopentyl}-3-{4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}urea Trimetaphan camsylate (3aS,4S,6aR)-4-hexyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one 1-Benzyl-1,3a,4,6,7,8,8a,8b-octahydrothieno[1',2':1,2]thieno[3,4-d]imidazol-5-ium-2-olate--hydrogen chloride (1/1) (3aα,6aα)-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazole (3aα,6aβ)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (E)-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pent-2-enoic acid (3aS,4Z,6aR)-1,3-dibenzyl-4-(3-methoxypropylidene)-6,6a-dihydro-3aH-thieno[3,4-d]imidazol-2-one (3aS,6aR)-1-Isopropyl-5,5-dioxo-hexahydro-5λ6-thieno[3,4-d]imidazol-2-one (3AS-cis)-1,3-dibenzyltetrahydro-4-(3-methoxypropylidene)-1H-thieno(3,4-d)imidazol-2(3H)-one (3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 2-oxo-(3ar,3bξ,8ac)-decahydro-thieno[1',2':1,2]thieno[3,4-b]imidazolium; bromide biotin hydrazide (3aS,4S,6aR)-1,3-bis[(3-bromophenyl)methyl]-4-(5-hydroxypentyl)-3a,4,6,6a-tetrahydrothieno[3,4-d]imidazol-2-one 4-Pentyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-3-benzyl-4-pentyl-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-4-hept-6-ynyl-2-oxo-tetrahydro-thieno[3,4-d]imidazole-1,3-dicarboxylic acid di-tert-butyl ester (3aS,4S,6aR)-4-(6-hydroxyhexyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-4-oct-7-ynyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoic acid 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentyl dimethyl phosphite Methyl-tetranorbiotinyl-keton (2aR,7aS,7bS)-Hexahydro-2H-1-thia-3,4a-diazacyclopent[cd]inden-4(3H)-one 8-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)octanoic acid 2'-thiobiotinol